GlaxoSmithKline (“GSK” or the “Company”) announced yesterday that it will stop paying health care professionals to promote its drug products and will no longer tie the compensation of its worldwide sales force to individual sales targets. In...
By: Mintz Levin - Health Law & Policy Matters
By: Mintz Levin - Health Law & Policy Matters